Expansion comes after IntelliSep ® helped reduce the risk-adjusted sepsis mortality index by 30% in first hospital deployment SAN FRANCISCO , Oct. 30, 2024 /PRNewswire/ -- Cytovale ® , a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced that Franciscan Missionaries of Our Lady (FMOL) Health System has expanded access to the IntelliSep ® rapid sepsis detection technology for patients at St. Dominic's Hospital in Jackson, Miss.
; St. Francis Medical Center in Monroe, La. ; and Our Lady of Lourdes Health , in Acadiana, La.
"After years of research at Our Lady of the Lake Regional Medical Center (OLOLRMC), we are excited to be the first health system in the country to bring the IntelliSep diagnostic to our emergency departments across every market we serve," said E.J. Kuiper, President and CEO of Franciscan Missionaries of Our Lady Health.
"This groundbreaking advancement underscores our commitment to pioneering innovative healthcare solutions and improving patient outcomes. Together, we are setting a new standard in early sepsis detection, ultimately saving lives and improving the quality of care we provide." IntelliSep is the first and only U.
S. Food and Drug Administration (FDA)-cleared cellular host diagnostic indicated for use in the emergency department (ED), where over 80% of sepsis cases present . The FMOL Health System was the first in the nation to deplo.